NMS STRATEGIES for INNOVATIVE FEDERAL STRATEGIES
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
H.R. 5293/S.3000, Department of Defense Appropriations Act, 2017, Title IV and VI, all provisions related to blood products and technologies (on behalf of Cerus). H.R. 2577, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, Divisions B, Title V, all provisions relating to supplemental fiscal year 2016 funds to combat the Zika outbreak (on behalf of Cerus). H.R. 5293/S.3000, Department of Defense Appropriations Act, 2017, Title IV, all provisions relating to test facilities and microprocessors for spacecraft (on behalf of Moog Inc.). H.R. 5293/S.3000, Department of Defense Appropriations Act, 2017, Title IV, all provisions relating to high performance computing (on behalf of Cray). H.R. 5293/S. 3000, Department of Defense Appropriations Act, 2017, Title III, all provisions relating to military ammunition; and Title IV, all provisions relating to demilitarization, decontamination, air purification systems, and rocket motors (on behalf of Day and Zimmermann).
| Lobbyist | Covered position, as disclosed |
|---|---|
| NEELY MARCUS SILBEY | Legislative Assistant, Office of SEN Patty Murray (WA) |
Government Issues GOV
Contacted Members of Congress on blood safety in blood banks and hospitals, and to provide information on Cerus' contact with BARDA for blood safety.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NEELY MARCUS SILBEY | Legislative Assistant, Office of SEN Patty Murray (WA) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.